Statistics
Total Visits
Views | |
---|---|
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the aristotle trial (apixaban for the prevention of stroke in subjects with atrial fibrillation)(legacy) | 272 |
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the aristotle trial (apixaban for the prevention of stroke in subjects with atrial fibrillation)(legacy) | 129 |
Total Visits per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the aristotle trial (apixaban for the prevention of stroke in subjects with atrial fibrillation) | 0 | 6 | 2 | 0 | 1 | 4 | 5 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
Australia | 121 |
Germany | 75 |
United States | 57 |
Vietnam | 9 |
Netherlands | 8 |
France | 7 |
China | 6 |
Singapore | 2 |
Brazil | 1 |
Ireland | 1 |
Top City Views
Views | |
---|---|
Kaleen | 77 |
Ashburn | 15 |
Hanoi | 9 |
Rotterdam | 8 |
Cambridge | 6 |
Fairfield | 5 |
Nürnberg | 4 |
Tettnang Castle | 4 |
Boardman | 2 |
Singapore | 2 |